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Dears Editors,
Negative symptoms in Schizophrenia consist 
of affective flattening, anhedonia, alogia, asociality, 
and avolition. These symptoms are the main predictors 
of functional outcomes resulting in poorer social and 
occupational functioning, in particular for patients with 
a young age of onset of the disorder1. Antipsychotic 
treatment evolved in the last five decades reaching a 
significant control over positive symptoms but still yield 
small to no effect results for negative symptoms2–4. Non-
invasive brain stimulation (NIBS) techniques emerged 
as an alternative to standard pharmacological treatment 
options.
The developments in functional neuroimaging 
and biomarkers enabled the better understanding of the 
cortical and subcortical areas involved in the negative 
symptoms of schizophrenia. The idea of modulating 
such dysfunctional areas in a controlled, focused way, 
in contrast to electroconvulsive therapy, enabled the 
rise of the NIBS field of study. This area comprehends 
the transcranial magnetic stimulation (TMS)5,6 and 
the transcranial direct current stimulation (tDCS)7. 
These techniques have been proved efficacious for 
neuroplasticity enhancement, boosting treatment response 
for refractory symptoms in different neurological and 
psychiatric disorders8,9. Although promising results 
have been previously reported on the effect of TMS and 
tDCS for negative symptoms in schizophrenia10, they 
are still controversial8. With the purpose of gathering the 
knowledge on the randomized controlled trials on NIBS 
for negative symptoms in schizophrenia, we conducted 
a systematic review and meta-analysis. We hypothesize 
that NIBS techniques are superior to sham stimulation for 
treatment of this symptom domain.
Our systematic review yielded 440 studies after 
duplicates were removed. In the end, 31 studies complied 
with inclusion criteria and were selected for the quantitative 
analysis (1272 patients). Studies sample sizes ranged from 
11 to 157 subjects, with mean ages of 38.8 years (SD = 
7.27) and 39.93 years (SD = 7.75) for the sham and active 
groups, respectively.
Quality assessment revealed that all studies were 
properly randomized, sham-controlled, with patient and 
evaluator blinded. Also, all studies scored at least 4 in the 
Jadad scale11.
As our primary outcome we found that active NIBS 
was significantly superior to sham NIBS calculating the 
effect size for the endpoint (g = 0.23; 95% CI 0.11 – 0.34). 
In general, heterogeneity was low and not significant in 
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our analysis (I2=2.3%, p=0.429 for the χ2 test) and the 
Egger’s test was not significant (p=0.179).
In accordance with previous meta-analytical studies 
that reported positive results using TMS and tDCS for the 
treatment of patients with psychiatric disorders9,12–14, we 
present compelling positive findings that encourage the 
perpetuation of the effort to find a way to the successful 
treatment of negative symptoms in schizophrenia.
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